Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Markus Scherer

Cardiovascular Disease Charlotte, NC Medical Doctor

NPI 1699771790 CMS profile 440007

1237 Harding Pl, Ste 3100, Charlotte, NC 28204

Open in the dashboard

General payments

$526,029

792 records reported · program years 2019–2025

Research payments

$6,400

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$149,306 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Markus Scherer of Charlotte, NC is reported in the CMS Open Payments database as having received $526,029 across 792 general payments and $6,400 in research payments paid to them. Separately, studies naming them as principal investigator received $149,306 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $112,574 137
2024 General $136,794 160
2024 Research $6,400 1
2023 General $64,724 150
2022 General $41,904 100
2021 General $47,775 40
2020 General $36,823 51
2019 General $85,434 154

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Markus Scherer
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Markus Scherer were reported at $112,574. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Markus Scherer Cardiovascular Disease median Middle half National median
2019 $85,434 $450 $127–$1,392 $163
2020 $36,823 $242 $77–$751 $114
2021 $47,775 $335 $101–$1,037 $132
2022 $41,904 $395 $121–$1,211 $149
2023 $64,724 $443 $136–$1,283 $160
2024 $136,794 $450 $136–$1,323 $164
2025 $112,574 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $210,184 279 payments
  2. Boston Scientific Corporation $118,161 220 payments
  3. Philips Electronics North America Corporation $76,738 56 payments
  4. Edwards Lifesciences Corporation $53,071 64 payments
  5. Siemens Medical Solutions USA, Inc. $39,495 57 payments
  6. HeartFlow, Inc. $27,902 108 payments
  7. Ge Healthcare $128 3 payments
  8. Vital Images, Inc. $116 1 payment
  9. Abiomed $107 1 payment
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $88 1 payment
  11. Other $39 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $244,147 61 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $144,394 59 payments
  3. Travel and Lodging $68,067 160 payments
  4. Honoraria $26,663 6 payments
  5. Food and Beverage $24,110 499 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $15,000 3 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $3,375 1 payment
  8. Gift $179 2 payments
  9. Grant $95 1 payment
Products named General payments · program years 2019–2025
  1. WATCHMAN Access System $68,156 91 payments
  2. Mitra Clip system $54,381 84 payments
  3. Edwards SAPIEN 3 Transcatheter Heart Valve $40,801 45 payments
  4. (9520) IGT Devices Undivided $37,504 11 payments
  5. MitraClip System $34,311 17 payments
  6. MITRACLIP Vascular $33,516 39 payments
  7. MITRACLIP Structural Heart $28,103 36 payments
  8. TRICLIP $19,235 29 payments
  9. FFRct $18,591 68 payments
  10. WATCHMAN FLX $18,086 81 payments
  11. Other $112,593 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Caption Health, Inc. $6,400 1 payment

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$64,697

Of which drugs: $2,817

Medicare patients

483

Average age 75

Services billed

9,650

242 women, 241 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 68%
Heart failure 60%
Atrial fibrillation 53%
Arthritis 50%
Chronic kidney disease 40%
Diabetes 38%
Depression 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, perflutren lipid microspheres, per ml Q9957 Office 39 47 $1,517
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 74 8,223 $817
Injection, regadenoson, 0.1 mg J2785 Office 17 59 $330
Injection, aminophyllin, up to 250 mg J0280 Office 15 15 $80

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

793 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record